Zhongmu Holdings: Obtained new veterinary drug registration certificate of trivalent inactivated vaccine for feline tracheitis, etc.

Sinomach Group announced that recently, the company's trivalent inactivated vaccine for feline tracheitis, feline calicivirus disease, and feline panleukopenia has been approved by the Ministry of Agriculture and Rural Affairs as a new veterinary drug, and has been issued a "New Veterinary Drug Registration Certificate" with a monitoring period of 3 years. This vaccine is a product independently developed by the company, using domestic main circulating strains, and has a good immune protection effect against feline related diseases. Obtaining the new veterinary drug registration certificate this time will enhance the company's competitiveness in the pet market and is of great significance for the development of the pet industry.